California Public Employees Retirement System
DRNA

California Public Employees Retirement System’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

California Public Employees Retirement System’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-115,259
Closed -$2.95M – 3372
2021
Q1 		$2.95M Sell
115,259
-25,212
-18% -$644K ﹤0.01% 1762
2020
Q4 		$3.1M Sell
140,471
-7,182
-5% -$158K ﹤0.01% 1719
2020
Q3 		$2.66M Buy
147,653
+2,663
+2% +$55.1K ﹤0.01% 1656
2020
Q2 		$3.68M Buy
144,990
+27,615
+24% +$595K ﹤0.01% 1400
2020
Q1 		$2.16M Sell
117,375
-1,800
-2% -$35K ﹤0.01% 1558
2019
Q4 		$2.63M Buy
119,175
+16,500
+16% +$332K ﹤0.01% 1867
2019
Q3 		$1.47M Buy
102,675
+35,836
+54% +$512K ﹤0.01% 2071
2019
Q2 		$1.05M Buy
66,839
+11,039
+20% +$150K ﹤0.01% 2128
2019
Q1 		$817K Sell
55,800
-52,787
-49% -$607K ﹤0.01% 2331
2018
Q4 		$1.16M Buy
108,587
+18,200
+20% +$239K ﹤0.01% 2094
2018
Q3 		$1.38M Buy
90,387
+33,387
+59% +$486K ﹤0.01% 2144
2018
Q2 		$698K Buy
57,000
+16,000
+39% +$201K ﹤0.01% 2507
2018
Q1 		$392K Hold
41,000
– – ﹤0.01% 2725
2017
Q4 		$370K Hold
41,000
– – ﹤0.01% 2777
2017
Q3 		$236K Hold
41,000
– – ﹤0.01% 2959
2017
Q2 		$130K Hold
41,000
– – ﹤0.01% 3118
2017
Q1 		$139K Hold
41,000
– – ﹤0.01% 3137
2016
Q4 		$118K Hold
41,000
– – ﹤0.01% 3203
2016
Q3 		$241K Hold
41,000
– – ﹤0.01% 3031
2016
Q2 		$123K Hold
41,000
– – ﹤0.01% 3279
2016
Q1 		$220K Hold
41,000
– – ﹤0.01% 3112
2015
Q4 		$487K Buy
+41,000
New +$469K ﹤0.01% 2789

Other funds holding DRNA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

California Public Employees Retirement System's DRNA Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2021, closing a stake of 115,259 shares — an estimated $2.95M sold.

California Public Employees Retirement System first reported a position in DRNA in Q4 2015 and held it in 22 quarters. The position peaked at $3.68M in Q2 2020. 203 funds tracked by Wall St. Rank hold DRNA as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 115,259 Dicerna Pharmaceuticals, Inc. shares in Q2 2021, an estimated $2.95M.
  • California Public Employees Retirement System first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2015 and held it in 22 quarters.
  • California Public Employees Retirement System's Dicerna Pharmaceuticals, Inc. position peaked at $3.68M in Q2 2020.
  • 203 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.